|
|
 |
|
Viewing report
|
|
|
|
Xhale Diagnostics, Inc. Product Pipeline Analysis
Global Markets Direct, Jan 2009, Pages: 18
Xhale Diagnostics, Inc. Product Pipeline Analysis
Summary
This report is an insightful source for data, analysis and strategic insights into a Scope’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.
Scope
- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.
Reasons to buy
- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
- Understand a companys strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
- Assess a companys future growth by determining its pipeline depth, for probable acquisition opportunities.
Customers who bought this item also bought
Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials
Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US
Best Practice for Clinical Monitoring
Companion Diagnostics - Global Strategic Business Report
Endpoints-Clinical Trials in Orphan Diseases - Highest Number of Terminated Trials Focused on Mulitiple Myeloma
Clinical Trial Recruitment Strategies: Optimizing Patient Recruitment and Retention in Late Stage Clinical Trials
NIR Diagnostics Inc. Product Pipeline Analysis
Perceptronix Medical Inc. Product Pipeline Analysis
Gene Express, Inc. Product Pipeline Analysis
Sorin S.p.A. (SRN) - Product Pipeline Analysis
|
|
|
|
